📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Abgenix

1.1 - Company Overview

Abgenix Logo

Abgenix

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of human therapeutic antibody discovery, development, and manufacturing for treating diseases such as cancer, inflammation, and metabolic disease. Pipeline includes antibody therapeutic product candidates in clinical trials, including Panitumumab (ABX-EGF).

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Abgenix

Onyvax Logo

Onyvax

HQ: United Kingdom Website
  • Description: Provider of cancer therapies that harness the immune system’s selective power to seek out and destroy tumor cells, specifically targeting cancer cells to improve effectiveness while minimizing side effects compared to conventional treatments.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Onyvax company profile →
MetrioPharm Logo

MetrioPharm

HQ: Switzerland Website
  • Description: Provider of clinical-stage pharmaceutical development for chronic inflammatory diseases including psoriasis, arthritis, and multiple sclerosis. Offers MP1032, an oral immune modulator that normalizes energy metabolism of inflammatory immune cells and reduces corticosteroid-associated side effects without immunosuppression, with Phase IIa efficacy in psoriasis and COVID-19 and preclinical efficacy in Rheumatoid Arthritis and Duchenne muscular dystrophy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full MetrioPharm company profile →
CytoImmune Therapeutics Logo

CytoImmune Therapeutics

HQ: United States Website
  • Description: Provider of engineered, allogeneic, tumor-reactive NK cell immunotherapies designed to attack cancer and stimulate immunity, including TRACK-NK medicines; off-the-shelf candidates CYTO NK-102 for NSCLC, CYTO NK-203 for PSCA+ solid tumors, CYTO NK-201 for FLT3 AML, and CYTO NK-301 for multiple myeloma; plus the Coalescent platform for triple-edited NK cells (CAR expression, soluble IL-15, BiKE secretion).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CytoImmune Therapeutics company profile →
Cidara Therapeutics Logo

Cidara Therapeutics

HQ: United States Website
  • Description: Provider of drug-Fc conjugate therapeutics built on the Cloudbreak platform, which couples targeted small molecules and peptides to a human antibody fragment (Fc) to inhibit disease targets and engage the immune system; includes CD388, a Phase 2 DFC for preventing seasonal influenza A and B, and CBO421, an IND-enabling oncology DFC targeting CD73 to enhance anti-tumor immunity.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cidara Therapeutics company profile →
Curevo Vaccine Logo

Curevo Vaccine

HQ: United States Website
  • Description: Provider of next-generation, non-mRNA vaccines for infectious diseases, developing Amezosvatein for the prevention of shingles and chickenpox.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Curevo Vaccine company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Abgenix

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Abgenix

2.2 - Growth funds investing in similar companies to Abgenix

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Abgenix

4.2 - Public trading comparable groups for Abgenix

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Abgenix

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Abgenix

What does Abgenix do?

Abgenix is a provider of human therapeutic antibody discovery, development, and manufacturing for treating diseases such as cancer, inflammation, and metabolic disease. Pipeline includes antibody therapeutic product candidates in clinical trials, including Panitumumab (ABX-EGF).

Who are Abgenix's competitors?

Abgenix's competitors and similar companies include Onyvax, MetrioPharm, CytoImmune Therapeutics, Cidara Therapeutics, and Curevo Vaccine.

Where is Abgenix headquartered?

Abgenix is headquartered in United States.

How many employees does Abgenix have?

Abgenix has 1,000 employees 🔒.

When was Abgenix founded?

Abgenix was founded in 2010 🔒.

What sector and industry vertical is Abgenix in?

Abgenix is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Abgenix

Who are the top strategic acquirers in Abgenix's sector and industry

Top strategic M&A buyers and acquirers in Abgenix's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Abgenix?

Top strategic M&A buyers groups and sectors for Abgenix include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Abgenix's sector and industry vertical

Which are the top PE firms investing in Abgenix's sector and industry vertical?

Top PE firms investing in Abgenix's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Abgenix's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Abgenix's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Abgenix's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Abgenix include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Abgenix's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Abgenix?

The key public trading comparables and valuation benchmarks for Abgenix include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Abgenix for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Abgenix with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Abgenix's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Abgenix with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Abgenix's' sector and industry vertical?

Access recent funding rounds and capital raises in Abgenix's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Abgenix